AIP
AMGN icon

ARS Investment Partners’s Amgen AMGN Stock Holding History

ARS Investment Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-20,769
Closed -$3.54M – 122
2018
Q1 		$3.54M Buy
20,769
+1,415
+7% +$260K 0.43% 49
2017
Q4 		$3.37M Sell
19,354
-1,065
-5% -$188K 0.41% 53
2017
Q3 		$3.81M Buy
20,419
+18,173
+809% +$3.22M 0.49% 48
2017
Q2 		$387K Hold
2,246
– – 0.05% 135
2017
Q1 		$369K Buy
2,246
+346
+18% +$57.5K 0.05% 134
2016
Q4 		$278K Buy
+1,900
New +$286K 0.04% 142

Other funds holding AMGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ARS Investment Partners's AMGN Position: Q2 2018 in Review

ARS Investment Partners sold out of Amgen (AMGN) in Q2 2018, closing a stake of 20,769 shares — an estimated $3.54M sold.

ARS Investment Partners first reported a position in AMGN in Q4 2016 and held it in 6 quarters. The position peaked at $3.81M in Q3 2017. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • ARS Investment Partners reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
  • ARS Investment Partners sold 20,769 Amgen shares in Q2 2018, an estimated $3.54M.
  • ARS Investment Partners first reported a position in Amgen in Q4 2016 and held it in 6 quarters.
  • ARS Investment Partners's Amgen position peaked at $3.81M in Q3 2017.
  • 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on ARS Investment Partners's 13F filing for Q2 2018, filed 13 Aug 2018.